Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
Akorn Gets Warning Letter from FDA
April 2, 2007
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
pharmamanufacturing
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Notable 2024 FDA decisions
Harnessing the power of bispecific antibodies
Virginia is for pharma lovers
Michael Annino/Shutterstock AI
Mining pharma's reshoring rush
Sponsored
Content
Special report: OT cybersecurity incident response — Are you ready?
Nevertheless, they persisted
Load More Content